NO20040210L - Fenylacetamido-tiazolderivater, fremgangsmate for deres fremstilling og deres anvendelse som antitumormidler - Google Patents

Fenylacetamido-tiazolderivater, fremgangsmate for deres fremstilling og deres anvendelse som antitumormidler

Info

Publication number: NO20040210L
Authority: NO; Norway
Prior art keywords: phenylacetamido; preparation; antitumor agents; thiazole derivatives; thiazole
Prior art date: 2001-07-19

Application number

NO20040210A

Other languages

English (en)

Inventor

Gabriella Traquandi

Marcella Nesi

Mario Varasi

Paolo Pevarello

Maria Gabriella Brasca

Barbara Salom

Anna Vulpetti

Manuela Villa

Raffaella Amici

Original Assignee

Pharmacia Italia Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-19

Filing date

2004-01-16

Publication date

2004-03-03

2004-01-16 Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa

2004-03-03 Publication of NO20040210L publication Critical patent/NO20040210L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Neurosurgery (AREA)
Immunology (AREA)
Neurology (AREA)
Communicable Diseases (AREA)
Vascular Medicine (AREA)
Virology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Pulmonology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20040210A 2001-07-19 2004-01-16 Fenylacetamido-tiazolderivater, fremgangsmate for deres fremstilling og deres anvendelse som antitumormidler NO20040210L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US90794701A	2001-07-19	2001-07-19
US35764202P	2002-02-20	2002-02-20
PCT/EP2002/007289 WO2003008365A2 (en)	2001-07-19	2002-07-02	Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents

Publications (1)

Publication Number	Publication Date
NO20040210L true NO20040210L (no)	2004-03-03

Family

ID=26999733

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20040210A NO20040210L (no)	2001-07-19	2004-01-16	Fenylacetamido-tiazolderivater, fremgangsmate for deres fremstilling og deres anvendelse som antitumormidler

Country Status (24)

Country	Link
US (1)	US20040235919A1 (no)
EP (1)	EP1406899B1 (no)
JP (1)	JP2004534857A (no)
KR (1)	KR100908794B1 (no)
CN (1)	CN1286835C (no)
AR (1)	AR036176A1 (no)
AT (1)	ATE345341T1 (no)
AU (1)	AU2002325860B2 (no)
BR (1)	BR0211265A (no)
CA (1)	CA2453294A1 (no)
CY (1)	CY1105948T1 (no)
CZ (1)	CZ2004107A3 (no)
DE (1)	DE60216097T2 (no)
DK (1)	DK1406899T3 (no)
EA (1)	EA007392B1 (no)
ES (1)	ES2274076T3 (no)
GE (1)	GEP20105095B (no)
IL (2)	IL159570A0 (no)
MX (1)	MXPA04000407A (no)
NO (1)	NO20040210L (no)
NZ (1)	NZ530524A (no)
PL (1)	PL367938A1 (no)
PT (1)	PT1406899E (no)
WO (1)	WO2003008365A2 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7572914B2 (en)	2003-12-19	2009-08-11	Takeda Pharmaceutical Company Limited	Kinase inhibitors
ATE404556T1 (de) *	2004-08-17	2008-08-15	Hoffmann La Roche	Substituierte hydantoine
EP1778669A2 (en)	2004-08-18	2007-05-02	Takeda San Diego, Inc.	Kinase inhibitors
TW200621766A (en) *	2004-09-17	2006-07-01	Hoffmann La Roche	Substituted hydantoins
US7713973B2 (en)	2004-10-15	2010-05-11	Takeda Pharmaceutical Company Limited	Kinase inhibitors
US8119655B2 (en)	2005-10-07	2012-02-21	Takeda Pharmaceutical Company Limited	Kinase inhibitors
SG175609A1 (en)	2006-10-09	2011-11-28	Takeda Pharmaceutical	Kinase inhibitors
US8168794B2 (en)	2008-03-03	2012-05-01	Novartis Ag	Pim kinase inhibitors and methods of their use
CN104334546B (zh)	2012-05-21	2017-05-03	诺华股份有限公司	作为激酶抑制剂的新的环‑取代的n‑吡啶基酰胺
HK1215579A1 (zh)	2012-11-29	2016-09-02	Karyopharm Therapeutics, Inc.	被取代的2，3-二氫苯並呋喃基化合物和其用途
CN105492437B (zh)	2013-07-03	2018-05-11	卡尔约药物治疗公司	取代的苯并呋喃基和苯并噁唑基化合物及其用途
US9994558B2 (en)	2013-09-20	2018-06-12	Karyopharm Therapeutics Inc.	Multicyclic compounds and methods of using same
MA42655A (fr)	2015-08-18	2021-04-07	Karyopharm Therapeutics Inc	Acrylamide de (s,e)-3-(6-aminopyridin-3-yl)-n-((5-(4-(3-fluoro-3-méthylpyrrolidine-1-carbonyl)phényl)-7-(4-fluorophényl)benzofuran-2-yl)méthyl) pour le traitement du cancer
WO2017117447A1 (en)	2015-12-31	2017-07-06	Karyopharm Therapeutics Inc.	Multicyclic compounds and uses thereof
CN112739695B (zh)	2018-09-17	2025-03-18	永进药品工业株式会社	新型噻唑衍生物及其药学上可接受的盐
KR102335637B1 (ko) *	2020-03-13	2021-12-06	영진약품 주식회사	신규한 cdk7 억제 화합물 및 이의 약제학적으로 허용가능한 염
CN112979636A (zh) *	2021-02-06	2021-06-18	绍兴文理学院	一种含苯硫醚结构的噻唑类化合物及其制备方法和应用
CN112979634A (zh) *	2021-02-06	2021-06-18	绍兴文理学院	一种含酰胺结构的噻唑类化合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6040321A (en) *	1997-11-12	2000-03-21	Bristol-Myers Squibb Company	Aminothiazole inhibitors of cyclin dependent kinases
US6214852B1 (en) *	1998-10-21	2001-04-10	Bristol-Myers Squibb Company	N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
GB9823871D0 (en) *	1998-10-30	1998-12-23	Pharmacia & Upjohn Spa	2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
US6114365A (en) *	1999-08-12	2000-09-05	Pharmacia & Upjohn S.P.A.	Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents

2002
- 2002-07-02 ES ES02760213T patent/ES2274076T3/es not_active Expired - Lifetime
- 2002-07-02 US US10/483,620 patent/US20040235919A1/en not_active Abandoned
- 2002-07-02 CZ CZ2004107A patent/CZ2004107A3/cs unknown
- 2002-07-02 DE DE60216097T patent/DE60216097T2/de not_active Expired - Lifetime
- 2002-07-02 DK DK02760213T patent/DK1406899T3/da active
- 2002-07-02 PT PT02760213T patent/PT1406899E/pt unknown
- 2002-07-02 CN CNB028143388A patent/CN1286835C/zh not_active Expired - Fee Related
- 2002-07-02 BR BR0211265-5A patent/BR0211265A/pt not_active IP Right Cessation
- 2002-07-02 JP JP2003513926A patent/JP2004534857A/ja not_active Ceased
- 2002-07-02 PL PL02367938A patent/PL367938A1/xx not_active Application Discontinuation
- 2002-07-02 EA EA200400208A patent/EA007392B1/ru not_active IP Right Cessation
- 2002-07-02 EP EP02760213A patent/EP1406899B1/en not_active Expired - Lifetime
- 2002-07-02 MX MXPA04000407A patent/MXPA04000407A/es active IP Right Grant
- 2002-07-02 GE GEAP200911511A patent/GEP20105095B/en unknown
- 2002-07-02 AU AU2002325860A patent/AU2002325860B2/en not_active Ceased
- 2002-07-02 WO PCT/EP2002/007289 patent/WO2003008365A2/en not_active Ceased
- 2002-07-02 IL IL15957002A patent/IL159570A0/xx not_active IP Right Cessation
- 2002-07-02 KR KR1020047000859A patent/KR100908794B1/ko not_active Expired - Fee Related
- 2002-07-02 CA CA002453294A patent/CA2453294A1/en not_active Abandoned
- 2002-07-02 NZ NZ530524A patent/NZ530524A/en not_active IP Right Cessation
- 2002-07-02 AT AT02760213T patent/ATE345341T1/de not_active IP Right Cessation
- 2002-07-18 AR ARP020102690A patent/AR036176A1/es unknown
2004
- 2004-01-16 NO NO20040210A patent/NO20040210L/no not_active Application Discontinuation
2007
- 2007-01-25 CY CY20071100090T patent/CY1105948T1/el unknown
2010
- 2010-04-08 IL IL204947A patent/IL204947A0/en unknown

Also Published As

Publication number	Publication date
KR20040030821A (ko)	2004-04-09
CN1531535A (zh)	2004-09-22
EP1406899B1 (en)	2006-11-15
JP2004534857A (ja)	2004-11-18
ES2274076T3 (es)	2007-05-16
DE60216097T2 (de)	2007-06-28
BR0211265A (pt)	2004-07-20
KR100908794B1 (ko)	2009-07-22
IL204947A0 (en)	2010-11-30
US20040235919A1 (en)	2004-11-25
IL159570A0 (en)	2004-06-01
DE60216097D1 (de)	2006-12-28
CZ2004107A3 (cs)	2004-04-14
PL367938A1 (en)	2005-03-07
GEP20105095B (en)	2010-10-25
CN1286835C (zh)	2006-11-29
HK1068336A1 (en)	2005-04-29
NZ530524A (en)	2006-12-22
AR036176A1 (es)	2004-08-18
CY1105948T1 (el)	2011-04-06
CA2453294A1 (en)	2003-01-30
EA200400208A1 (ru)	2004-06-24
ATE345341T1 (de)	2006-12-15
WO2003008365A2 (en)	2003-01-30
AU2002325860B2 (en)	2008-03-13
EA007392B1 (ru)	2006-10-27
MXPA04000407A (es)	2004-03-18
WO2003008365A3 (en)	2004-02-12
PT1406899E (pt)	2007-01-31
DK1406899T3 (da)	2007-04-02
EP1406899A2 (en)	2004-04-14

Publication	Publication Date	Title
NO20020684D0 (no)	2002-02-11	Aminopyrazolderivater, fremgangsmåte for deres fremstilling og deres anvendelse som antitumormidler
NO20012058L (no)	2001-06-28	2-ureido-tiazolderivater, fremgangsmåte for deres fremstilling og anvendelse som antitumormidler
NO20012057D0 (no)	2001-04-26	2-amino-tiazolderivater, fremgangsmåte for deres fremstilling og anvendelse som antitumormidler
DK1425014T3 (da)	2007-04-10	Diarylcycloalkylderivater, fremgangsmåde til deres fremstilling og deres anvendelse som PPAR-aktivatorer
DK1368349T3 (da)	2007-05-21	Xanthinderivater, deres fremstilling og deres anvendelse som lægemidler
NO20035298D0 (no)	2003-11-28	CDK-inhiberende pyrimider, deres fremstilling og deres anvendelse som legemidler
NO20020687L (no)	2002-04-03	3(5)-ureido-pyrazolderivater, fremgangsmåte for fremstilling av disse og deres anvendelse som antitumormidler
NO20025879L (no)	2003-01-29	Acylfenylureaderivater, fremgangsmåter for fremstilling derav og deres anvendelse som legemiddel
DK1204649T3 (da)	2007-12-03	Arylmethylcarbonylaminothiazolderivater og deres anvendelse som antitumormidler
NO20035366D0 (no)	2003-12-02	Benzoylsulfonamider og sulfonylbenzamidiner for anvendelse som antitumormidler
NO20020811D0 (no)	2002-02-19	Sulfonylkarboksamidderivater, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler
DK1381605T3 (da)	2005-05-09	Mercaptoacetylamidderivater, en fremgangsmåde til deres fremstilling og deres anvendelse
DK1445252T3 (da)	2006-06-19	Sulfonamid-derivater, deres fremstilling og anvendelse som medikamenter
NO20042279L (no)	2004-06-02	Kinazolinderivater som antitumormidler
NO20025150L (no)	2002-12-16	2-acylindolderivater og deres anvendelse som antitumormidler
NO20040210L (no)	2004-03-03	Fenylacetamido-tiazolderivater, fremgangsmate for deres fremstilling og deres anvendelse som antitumormidler
NO20042635L (no)	2004-06-23	5-Sulfanyl-ñH-1,2,4-triazol-derivater og deres anvendelse som medisin
NO20024749L (no)	2002-12-03	Indolin-2-on-derivater, deres fremstilling og anvendelse som ocytocinreseptor-ligander
DK1670458T3 (da)	2007-04-23	1-Amino-2-oxy-substituerede tetrahydronaphthalenderivater, fremgangsmåder til fremstilling deraf og deres anvendelse som antiphlogistika
DK1370550T3 (da)	2007-09-03	Quinolylpropylpiperidinderivater, deres fremstilling og præparater indeholdende dem
NO20043349L (no)	2004-10-05	Kumarinderivater, fremgangsmate for deres framstilling og anvendelse derav
DK1387838T3 (da)	2006-08-14	Cyanoanthranylamid-derivater og deres anvendelse som lægemidler
NO20033120L (no)	2003-09-11	2-arylimino-2,3-dihydrotiazolderivater, fremgangsmåter for fremstilling derav og terapeutisk anvendelse derav
DK1373249T3 (da)	2005-08-22	Imidazolidinderivater, deres fremstilling og deres anvendelse som anti-inflammatorisk middel
NO20033965L (no)	2003-09-08	Caloporosidderivater, fremgangsmåte for deres fremstilling og deres anvendelse

Legal Events

Date	Code	Title	Description
2012-02-20	FC2A	Withdrawal, rejection or dismissal of laid open patent application